Research

Pest control

By Jeff Carlton and Jan Jarvis   At a glance The threat Mosquitos, ticks and other biting arthropods can transmit serious diseases to humans,    ranging from West Nile virus to Lyme disease. The response UNTHSC researchers are seeking better preventative agents and more effective monitoring systems to counter these nasty disease-carriers. The bottom line Because... Read more »

Dec 1, 2016

Hongli Wu

Could grapes be the ‘magic bullet’ for cataracts?

By Jan Jarvis   Grapes are more than sweet treats in the eyes of one UNT Health Science Center researcher, who is studying how the fruit can prevent cataracts. Whether they’re green, red or black, grapes appear to have significant health benefits, said Hongli Wu, PhD, Assistant Professor of Pharmaceutical Sciences and in the North... Read more »

Nov 21, 2016

Eye Research Institute pateient

Video: Supporting eye research at UNT Health Science Center

The human eye is a complex and confounding organ that processes light, interprets shapes and allows us to see the world in all its beauty and variety. Diseases that damage and destroy eyesight can have a devastating effect on a person’s health, independence and quality of life. At UNT Health Science Center’s North Texas Eye... Read more »

Nov 18, 2016

Sid O'Bryant

A precision medicine approach to Alzheimer’s disease

By Jan Jarvis   Can an anti-inflammatory drug commonly used for headaches possibly treat or prevent Alzheimer’s disease? The answer might depend on who’s taking the drug, according to Sid O’Bryant, PhD, Professor in the Center for Alzheimer’s and Neurodegenerative Disease Research at UNT Health Science Center. There’s substantial evidence that non-steroidal anti-inflammatory drugs (NSAID)... Read more »

Nov 16, 2016

katalin-prokai-tatrai

A potential ‘game changer’ for eye disease

By Jan Jarvis An eye drop that could prevent blindness caused by glaucoma is one step closer to becoming a reality. A novel pharmacological intervention to control retinal ganglion cell death caused by glaucoma is in preclinical development, said Katalin Prokai-Tatrai, PhD, Associate Professor in the Center for Neuroscience Discovery and the Department of Pharmaceutical Sciences... Read more »

Nov 8, 2016

Mao and Kettles

A gift to improve glaucoma care

By Jan Jarvis   Mike Kettles was in the Navy and about to deploy overseas when he learned during a physical that he had glaucoma. “I was young and I was shocked,” he said. “With glaucoma you don’t feel like anything is wrong – but it is.” He was prescribed eye drops, which helped dramatically.... Read more »

Nov 4, 2016

Interdisciplinary Research and Education Building

Breaking ground on UNTHSC’s future

By Jeff Carlton When it opens in 2018, the building going up along Camp Bowie Boulevard will be more than just the first new research facility at UNT Health Science Center in 14 years. Housed inside an exterior of precast concrete, limestone walls and glass panels will be a building whose very design reflects the... Read more »

Oct 24, 2016

ruhani ahluwalia

‘Curiosity and perseverance’

By Jan Jarvis   Most tweens spend their free time playing video games, posting pics or taking selfies. Ruhani Ahluwalia, 12, spends her time doing research at UNT Health Science Center that could one day lead to a better method for cancer treatment with minimal side effects. “I just really like science and want to... Read more »

Oct 4, 2016

Dr Forster

The science of aging

By Jan Jarvis Today there are more than 75,000 centenarians living in the United States, a number that is expected to grow to 600,000 by mid-century. Why some people reach that milestone while others are burdened with diseases is at the crux of the International Conference on Aging and Disease, beginning Friday at the Stanford... Read more »

Sep 26, 2016

john schetz and derek schreihofer

New strategies for treating strokes

By Jan Jarvis   When someone has an ischemic stroke – meaning a brain blood vessel is blocked – every minute counts in the race to reduce damage. But getting the clot-busting drug tPA in time is challenging for the 800,000 Americans who experience a stroke each year, said John A. Schetz, PhD, Professor of... Read more »

Sep 16, 2016